Camille Locht is Research Director at the French National Institute of Health and Medical Research (Inserm) and was the founding director of the Center for Infection and Immunity of Lille at the Institut Pasteur de Lille (IPL). He has obtained his PhD at the Catholic University of Leuven. After a 3-year post-doctoral stay at the NIH, USA, he joined SmithKline–Beecham in 1989 at IPL, where he was the Scientific Director from 2002 to 2013. His main interest is in bacterial pathogenesis and vaccine development against respiratory disease, including pertussis and tuberculosis.